BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22964594)

  • 21. Therapy-related acute myeloid leukemia and myelodysplastic syndrome after hematopoietic cell transplantation for lymphoma.
    Yamasaki S; Suzuki R; Hatano K; Fukushima K; Iida H; Morishima S; Suehiro Y; Fukuda T; Uchida N; Uchiyama H; Ikeda H; Yokota A; Tsukasaki K; Yamaguchi H; Kuroda J; Nakamae H; Adachi Y; Matsuoka KI; Nakamura Y; Atsuta Y; Suzumiya J
    Bone Marrow Transplant; 2017 Jul; 52(7):969-976. PubMed ID: 28368379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second malignant neoplasms after childhood cancer: A nationwide population-based study in Korea.
    Ju HY; Moon EK; Lim J; Park BK; Shin HY; Won YJ; Park HJ
    PLoS One; 2018; 13(11):e0207243. PubMed ID: 30440007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.
    Meadows AT; Friedman DL; Neglia JP; Mertens AC; Donaldson SS; Stovall M; Hammond S; Yasui Y; Inskip PD
    J Clin Oncol; 2009 May; 27(14):2356-62. PubMed ID: 19255307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.
    Turcotte LM; Whitton JA; Friedman DL; Hammond S; Armstrong GT; Leisenring W; Robison LL; Neglia JP
    J Clin Oncol; 2015 Nov; 33(31):3568-75. PubMed ID: 26261260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varicella Zoster Virus Infection in Children with Autologous Hematopoietic Cell Transplantation: A Retrospective, Single-Center Study in Korea.
    Kang JM; Kim JM; Lee JW; Yoo KH; Sung KW; Koo HH; Kim YJ
    Biol Blood Marrow Transplant; 2020 May; 26(5):965-971. PubMed ID: 31962166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults.
    Kube SJ; Blattmann C; Bielack SS; Kager L; Kaatsch P; Kühne T; Sorg B; Kevric M; Jabar S; Hallmen E; Sparber-Sauer M; Klingebiel T; Koscielniak E; Dirksen U; Hecker-Nolting S; Gerß JWO
    Cancer; 2022 May; 128(9):1787-1800. PubMed ID: 35195899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of developing second malignant neoplasms in patients with neuroblastoma: a population study of the US SEER database.
    Zhen H; Guan H; Ma J; Wang W; Jing S; Miao Z; Zhang F; Liu Z
    Radiat Oncol; 2021 Nov; 16(1):228. PubMed ID: 34838090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
    Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
    J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning.
    Majhail NS; Brazauskas R; Rizzo JD; Sobecks RM; Wang Z; Horowitz MM; Bolwell B; Wingard JR; Socie G
    Blood; 2011 Jan; 117(1):316-22. PubMed ID: 20926773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
    Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE
    Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.
    Applebaum MA; Henderson TO; Lee SM; Pinto N; Volchenboum SL; Cohn SL
    Pediatr Blood Cancer; 2015 Jan; 62(1):128-33. PubMed ID: 25251613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excess risk of subsequent malignant neoplasms in adolescent and young adult cancer survivors: Results from the first Italian population-based cohort.
    Trama A; Tittarelli A; Barigelletti G; Botta L; Gatta G; Tagliabue G; Contiero P; Guzzinati S; Andreano A; Manneschi G; Falcini F; Castaing M; Filiberti RA; Gasparotti C; Cirilli C; Mazzucco W; Mangone L; Iacovacci S; Vitale MF; Stracci F; Piffer S; Tumino R; Carone S; Sampietro G; Melcarne A; Ballotari P; Boschetti L; Pisani S; Cavalieri D'Oro L; Cuccaro F; D'Argenzio A; D'Orsi G; Fanetti AC; Ardizzone A; Candela G; Savoia F; Pascucci C; Castelli M; Storchi C; Bernasconi A
    Cancer; 2022 Jan; 128(2):364-372. PubMed ID: 34582036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy.
    O'Brien MM; Donaldson SS; Balise RR; Whittemore AS; Link MP
    J Clin Oncol; 2010 Mar; 28(7):1232-9. PubMed ID: 20124178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.
    Atsuta Y; Suzuki R; Yamashita T; Fukuda T; Miyamura K; Taniguchi S; Iida H; Uchida T; Ikegame K; Takahashi S; Kato K; Kawa K; Nagamura-Inoue T; Morishima Y; Sakamaki H; Kodera Y;
    Ann Oncol; 2014 Feb; 25(2):435-41. PubMed ID: 24399081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group.
    Breslow NE; Takashima JR; Whitton JA; Moksness J; D'Angio GJ; Green DM
    J Clin Oncol; 1995 Aug; 13(8):1851-9. PubMed ID: 7636528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of second malignant neoplasms in women and girls with germ cell tumors.
    Liao Z; Rodrigues MC; Poynter JN; Amatruda JF; Rodriguez-Galindo C; Frazier AL
    Ann Oncol; 2017 Feb; 28(2):329-332. PubMed ID: 27864217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
    Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
    Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second malignant neoplasms in long-term survivors of osteosarcoma: Memorial Sloan-Kettering Cancer Center Experience.
    Aung L; Gorlick RG; Shi W; Thaler H; Shorter NA; Healey JH; Huvos AG; Meyers PA
    Cancer; 2002 Oct; 95(8):1728-34. PubMed ID: 12365021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second malignant neoplasms following childhood cancer: a study of a recent cohort (1987-2004) from the childhood cancer registry of the Rhône-Alpes region (ARCERRA) in France.
    Berger C; Trombert-Paviot B; Casagranda L; Mialou V; Frappaz D; Plantaz D; Collardeau-Frachon S; Freycon F
    Pediatr Hematol Oncol; 2011 Aug; 28(5):364-79. PubMed ID: 21736475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis.
    Forrest DL; Nevill TJ; Naiman SC; Le A; Brockington DA; Barnett MJ; Lavoie JC; Nantel SH; Song KW; Shepherd JD; Sutherland HJ; Toze CL; Davis JH; Hogge DE
    Bone Marrow Transplant; 2003 Nov; 32(9):915-23. PubMed ID: 14561993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.